Manufacturing, latest filing in May 2026

The Compensation Committee (the "Committee") of the Board of Directors of Allison Transmission Holdings, Inc. (the "Company") previously approved the Executive Change in Control and Severance Plan (the "Severance Plan"), which provides severance benefits to senior level employees of Allison Transmission, Inc., a wholly owned subsidiary of the Company, and designated Eric C. Scroggins, the Chief Legal Officer and Assistant Secretary of the Company, as a Tier 1/2 Participant in the Severance Plan.

Also stated in this filing

• On May 6, 2026, the Committee approved Mr. Scroggins' participation in the Severance Plan as a Tier 1 Participant.
• The Severance Plan is listed as an exhibit to the Company's most recently filed Annual Report on Form 10-K.

Nick L. Stanage was appointed to the Board of Directors of AMETEK, Inc., or the "Company" effective May 7, 2026 to serve as a Class III Director until the 2027 Annual Meeting.

Also stated in this filing

• Mr. Stanage joins the Board as an independent director.
• Non-employee directors receive compensation for service as a director which includes an annual basic retainer fee of $120,000, payable in advance in equal quarterly installments.
• Accordingly, Mr. Stanage will receive the pro rata portion of the annual fee for 2026.
• Non-employee directors also receive an annual equity award with a target value of $210,000.
• Accordingly, Mr. Stanage will receive a pro rata equity award.
• Additionally, non-employee directors are reimbursed for expenses related to their Board service.

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").

Also stated in this filing

• Mr. Raykov's current term will expire immediately following the Annual Meeting.
• Mr. Raykov's departure is not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
• Prior to the Annual Meeting, the Board determined to reduce the size of the Board from six directors to five directors effective immediately following the Annual Meeting.
• Following the Annual Meeting and Mr. Raykov's departure, the Company expects that there will be no vacancies on the Board.

Following the 2026 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. held on May 11, 2026, the newly constituted Board of Directors elected Beverly Huss to serve as the Chairman of the Board of Directors.

Also stated in this filing

• - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective Time, Richard E. Allison, Jr., Larry J. Merlo, and Kirk L. Perry (collectively, the "Kenvue Designees"), each of whom was a member of the board of directors of Kenvue prior to the First Effective Time, were appointed to the board of directors of K-C (the "Board").

Also stated in this filing

• K-C has agreed to take all necessary actions to nominate the Kenvue Designees for election to the Board at the annual meeting of stockholders of K-C to be held in 2027.
• Also at the First Effective Time, Mr. Allison was appointed to the Audit Committee of the Board, and Mr. Merlo was appointed to the Management Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board.
• Mr. Perry was not appointed to any committees of the Board.
• The Kenvue Designees will participate in the outside director compensation programs described under "Director Compensation" in K-C's Definitive Proxy Statement on Schedule 14A filed on March 23, 2026.
• The resignations of Dr. Jemison, Ms. Quarles and Mr. Ramirez were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices but were solely for the purpose of creating adequate vacancies on the Board to allow for the appointment of the Kenvue Designees.

On September 29, 2026, Russell Torres, the Corporation's President and Chief Operating Officer, notified the Corporation that he will depart the Corporation effective November 2, 2026 to pursue other opportunities.

On May 1, 2026, Andrew Scribner, the Corporation's Vice President and Controller, notified the Corporation that he will depart the Corporation effective May 22, 2026 to pursue other opportunities.

Also stated in this filing

• The Corporation's Senior Vice President and Chief Financial Officer, Nelson Urdaneta, will act as the Corporation's principal accounting officer effective upon Mr. Scribner's departure on an interim basis and in addition to his current duties.

On March 31, 2026, Kathleen F. Burke notified MKS Inc. (the "Corporation") of her intent to retire as Executive Vice President, General Counsel and Secretary of the Corporation effective June 1, 2026.

Also stated in this filing

• Ms. Burke will remain employed in the role of special advisor to the Corporation until July 1, 2026.

Effective May 18, 2026, Bernardo Parlange was appointed as the Company's Chief Commercial Officer, a newly created role where Mr. Parlange will oversee the Company's global commercial strategy, including sales, marketing, and customer success.

Also stated in this filing

• On May 6, 2026, Proto Labs, Inc. (the "Company") announced that Michael R. Kenison, Chief Operations Officer, intends to retire effective July 1, 2026.
• The Company thanks Mr. Kenison for his years of service and wishes him the very best in his retirement.

On May 5, 2026, Aditya Gandhi informed Sonoco Products Company (the "Company") of his intention to resign from his position as Chief Accounting Officer, effective May 29, 2026.

Also stated in this filing

• Mr. Gandhi's decision to resign was not the result of any disagreement with the Company or its Board of Directors relating to the Company's operations, policies or practices or any issues regarding its accounting policies or practices.
• Paul Joachimczyk, the Company's Chief Financial Officer, will assume the responsibilities of principal accounting officer until a successor principal accounting officer is appointed.

On November 2, 2026, the board of directors (the "Board") of Trimble Inc. (the "Company") appointed Matthew C. Brown to serve as a director of the Company, effective November 2, 2026.

Also stated in this filing

• Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.
• Mr. Brown was concurrently appointed by the Board to serve as a member of the Audit Committee of the Board.
• Mr. Brown has served as Chief Financial Officer of Tenable Holdings, Inc., a provider of cybersecurity exposure management solutions, since August 2025.
• Prior to joining Tenable, Mr. Brown served as the Chief Financial Officer of Altair Engineering Inc. from January 2021 to March 2025.
• His previous experience includes other finance and accounting leadership roles in the technology sector, and he is a Certified Public Accountant.
• In addition, the Company intends to enter into its standard form indemnification agreement with Mr. Brown.

(b) On May 26, 2026, Mark S. Peek notified the Board of Directors (the "Board") of Trimble Inc. (the "Company") that he has resigned from his role as a director of the Board, effective immediately.

In connection with his resignation from the Board, Mr. Peek also stepped down as Chair of the Audit Committee and is no longer a member of the Audit Committee nor of the Nominating and Corporate Governance Committee.

Also stated in this filing

• Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.
• Therefore, Mr. Peek will not be standing for reelection at the Company's 2026 Annual Meeting of Stockholders (the "Annual Meeting") to be held today, on May 26, 2026, at 5:00 p.m.
• As a result, any votes cast regarding the election of Mr. Peek at the Annual Meeting will not be counted.
• Mr. Peek's decision to resign from the Board is not due to any disagreement with the Company on any matter relating to its operations, policies or practices.
• With the resignation of Mr. Peek, effective immediately, the Board reduced the size of its membership from nine to eight directors.

On May 12, 2026, Mickie Henshall notified the Board of Directors (the "Board") of VolitionRx Limited (the "Company") of her decision not to stand for re-election to the Board at the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting").

Also stated in this filing

• Ms. Henshall has served on the Board since August 2022.
• Ms. Henshall's decision not to stand for re-election did not involve any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

In addition, Mr. Das was appointed as a member of the Audit Committee of the Board.

Also stated in this filing

• On May 26, 2026, the Board of Directors (the "Board") of Western Digital Corporation (the "Company") unanimously appointed Manuvir Das to serve as a member of the Board until the Company's next annual meeting of stockholders and until his successor is duly elected and qualified.